, Vietnam
Photo by Tron Le from Unsplash

VINARE to maintain robust performance: AM Best

Its return-on-equity ratio for the past five years proved better incoming performance.

Vietnam National Reinsurance Corporation's (VINARE) 2022 performance was perceived as strong and stable, according to credit rating agency AM Best.

VINARE’s 2022 financial performance reflected strong risk-adjusted capitalisation.

As measured by Best’s Capital Adequacy Ratio (BCAR), VINARE’s capital adequacy ratio is supported by its conservative net underwriting leverage and exceptional selection of retrocessionaires.

Likewise, the reinsurer surpassed the minimum requirement for regulatory solvency during the year as personal accident premiums were reduced.

ALSO READ: Tune Protect Re to diversify in the medium term: AM Best

“Offsetting factors to the company’s balance sheet strength include its moderate investment risk, high dividend payout ratio and exposure to catastrophe risk,” said AM Best.

Due to VINARE’s five-year weighted average of 9.9% in return-on-equity ratio, AM Best describes the firm to have a strong operating performance.

“Prospectively, AM Best expects the company to maintain its strong level of operating performance, supported by controlled underwriting growth and improved pricing conditions in its core lines of business.” stated AM Best.

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.